Chia Tai Enterprises International stock analysis
Chia Tai Enterprises International (CAIHF) Stock Price & Analysis
CAIHF Stock Chart & Stats
- Day’s Range
- $0.83 - $1.06
- 52-Week Range
- $0.28 - $1.07
- Previous Close
- $0.96
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- $242.16M
- Enterprise Value
- $2.75B
- Total Cash (Recent Filing)
- $37.25M
- Total Debt (Recent Filing)
- $75.56M
- Price to Earnings (P/E)
- 9.9
- Beta
- 9.71
- Next Earnings
- Nov 11, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Rebound
The sharp 2025 revenue rebound shows materially stronger business activity after a weaker prior year. If sustained, the larger revenue base can improve operating leverage, support broader distribution of animal-health products, and provide greater capacity to fund ongoing operations and growth.
Improved Profitability
Higher net and operating margins indicate that the recent revenue recovery translated into better profitability, not just increased sales volume. This strengthens earnings quality in the near term and gives management more room to absorb costs, reinvest, and build durable returns if margins hold.
Conservative Balance Sheet
Falling leverage and expanding equity provide a stronger financial base for the company. Lower debt dependence should reduce balance-sheet strain and preserve flexibility for operations or investment, while the improved 11.6% return on equity suggests capital was being used more effectively in 2025.
Bears Say
Gross Margin Compression
The sustained gap between the latest gross margin and earlier levels indicates that underlying pricing or cost pressure remains important despite the revenue rebound. Lower gross profitability leaves less room to cover operating expenses and makes future earnings more sensitive to execution and product mix.
Uneven Cash Generation
A history of inconsistent operating and free cash flow shows that reported earnings have not reliably converted into liquidity across the cycle. This can constrain internally funded investment and make cash availability more dependent on working-capital performance or changes in operating conditions.
Earnings Volatility
The move from a loss in 2022 to improved profitability in 2025 demonstrates a volatile earnings profile rather than a consistently strong record. Such variability increases the risk that future performance will depend heavily on maintaining the recent recovery and controlling costs as conditions change.
Chia Tai Enterprises International News
CAIHF FAQ
What was Chia Tai Enterprises International’s price range in the past 12 months?
What is Chia Tai Enterprises International’s market cap?
When is Chia Tai Enterprises International’s upcoming earnings report date?
How were Chia Tai Enterprises International’s earnings last quarter?
Is Chia Tai Enterprises International overvalued?
Does Chia Tai Enterprises International pay dividends?
What is Chia Tai Enterprises International’s EPS estimate?
How many shares outstanding does Chia Tai Enterprises International have?
What happened to Chia Tai Enterprises International’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Chia Tai Enterprises International?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Chia Tai Enterprises International
CPBIO Holding Company Limited produces and distributes chlortetracycline (CTC) and related goods. Its extensive international reach covers Mainland China, the Asia Pacific region, the Americas, and Europe. The company's operations are divided into two distinct divisions: Biochemical and Industrial. The Biochemical division focuses on the manufacturing and supply of CTC premix and CTC hydrochloride products. These are employed as feed supplements to encourage livestock growth, prevent or cure animal illnesses, and improve feed conversion, sold under the brands Shihao and Citifac. Conversely, the Industrial segment handles the sales, rental, and maintenance of heavy construction machinery, encompassing items such as excavators, power generators, bulldozers, compactors, and their spare parts. This division also fabricates and markets carburetors and other automotive components for various automobile and motorcycle manufacturers. Founded in 1987, the company maintains its headquarters in Central, Hong Kong, and functions as a subsidiary of Charoen Pokphand Foods Public Company Limited.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Chawalit Na Muangtoun
- Employees
- 1,000
- Website
- www.cp-bio.com
- Address
- HK
Chia Tai Enterprises International (CAIHF) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 8 | 3 | 10 |
| Technical Analysis | 4 | 3 | 2 |
| Moving Averages | 4 | 0 | 8 |








